Simplex Trading
GBIO

Simplex Trading’s Generation Bio GBIO Stock Holding History

Simplex Trading’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-17
Closed -$450 – 8864
2024
Q2 		$0 Sell
17
-2,492
-99% -$81K ﹤0.01% 9127
2024
Q1 		$102K Buy
2,509
+1,227
+96% +$28.9K ﹤0.01% 5547
2023
Q4 		$21K Buy
1,282
+1,236
+2,687% +$21.6K ﹤0.01% 6881
2023
Q3 		$1K Buy
46
+23
+100% +$1.09K ﹤0.01% 8308
2023
Q2 		$1K Sell
23
-2
-8% -$92 ﹤0.01% 8617
2023
Q1 		$1K Buy
+25
New +$1.21K ﹤0.01% 8691
2022
Q1 		– Sell
-467
Closed -$27.1K – 10731
2021
Q4 		$33K Sell
467
-1,836
-80% -$321K ﹤0.01% 7771
2021
Q3 		$631K Sell
2,303
-137
-6% -$32.8K ﹤0.01% 3736
2021
Q2 		$656K Sell
2,440
-3,163
-56% -$946K ﹤0.01% 3746
2021
Q1 		$1.59M Buy
+5,603
New +$1.79M ﹤0.01% 1870

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Simplex Trading's GBIO Position: Q3 2024 in Review

Simplex Trading sold out of Generation Bio (GBIO) in Q3 2024, closing a stake of 17 shares — an estimated $450 sold.

Simplex Trading first reported a position in GBIO in Q1 2021 and held it in 10 quarters. The position peaked at $1.59M in Q1 2021. 75 funds tracked by Wall St. Rank hold GBIO as of Q3 2024.

  • Simplex Trading reported no remaining Generation Bio position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 17 Generation Bio shares in Q3 2024, an estimated $450.
  • Simplex Trading first reported a position in Generation Bio in Q1 2021 and held it in 10 quarters.
  • Simplex Trading's Generation Bio position peaked at $1.59M in Q1 2021.
  • 75 funds tracked by Wall St. Rank held Generation Bio as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.